Journal of Medicinal Chemistry
Brief Article
(6) Semenza, G. L. Regulation of hypoxia-induced angiogenesis: a
chaperone escorts VEGF to the dance. J. Clin. Invest. 2001, 108, 39−
40.
(7) Graeber, T. G.; Osmanian, C.; Jacks, T.; Housman, D. E.; Koch,
C. J.; Lowe, S. W.; Giaccia, A. J. Hypoxia-mediated selection of cells
with diminished apoptotic potential in solid tumours. Nature 1996,
379, 88−91.
(8) Overgaard, J.; Overgaard, M.; Timothy, A. R. Studies of the
pharmacokinetic properties of nimorazole. Br. J. Cancer 1983, 48, 27−
34.
and structure of 2-arenesulfonyl-3-aryloxaziridines. A new class of
oxaziridine. J. Am. Chem. Soc. 1980, 102, 2000−2005.
(25) Hazlehurst, L. A.; Krapcho, A. P.; Hacker, M. P. Comparison of
aza-anthracenedione-induced DNA damage and cytotoxicity in
experimental tumor cells. Biochem. Pharmacol. 1995, 50, 1087−1094.
(26) Hazlehurst, L. A.; Krapcho, A. P.; Hacker, M. P. Correlation of
DNA reactivity and cytotoxicity of a new class of anticancer agents:
aza-anthracenediones. Cancer Lett. 1995, 91, 115−124.
(9) Teicher, B. A. Hypoxia and drug resistance. Cancer Metastasis Rev.
1994, 13, 139−168.
(10) Craighead, P. S.; Pearcey, R.; Stuart, G. A phase I/II evaluation
of tirapazamine administered intravenously concurrent with cisplatin
and radiotherapy in women with locally advanced cervical cancer. Int. J.
Radiat. Oncol., Biol., Phys. 2000, 48, 791−795.
(11) Cerecetto, H.; Gonzalez, M.; Lavaggi, M. L.; Azqueta, A.; Lopez
́ ́
de Cerain, A.; Monge, A. Phenazine 5,10-dioxide derivatives as hypoxic
selective cytotoxins. J. Med. Chem. 2005, 48, 21−23.
(12) Krapcho, A. P.; Maresch, M. J.; Hacker, M. P.; Hazelhurst, L.;
Menta, E.; Oliva, A.; Spinelli, S.; Giuliani, F. C.; Beggiolin, G.; Pezzoni,
G.; Tognella, S. Anthracene-9,10-diones and aza bioisosteres as
antitumor agents. Curr. Med. Chem. 1995, 2, 803−824.
(13) Wiernik, P. H. In Anthracyclines: Current Status and New
Developments; Crooke, S. T., Reich, S. D., Eds.; Acadamic Press: New
York, 1980; pp 273−294.
(14) Bailly, J. D.; Skladanowski, A.; Bettaieb, A.; Mansat, V.; Larsen,
A. K.; Laurent, G. Natural resistance of acute myeloid leukemia cell
lines to mitoxantrone is associated with lack of apoptosis. Leukemia
1997, 11, 1523−1532.
(15) Krapcho, A. P.; Menta., E; Oliva, A; Di Domenico, R; Fiocchi,
L.; Maresch, M. E.; Gallagher, C. E.; Hacker, M. P.; Beggiolin, G.;
Giuliani, F. C.; Pezzoni, G.; Spinelli, S. Synthesis and antitumor
evaluation of 2,5-disubstituted-indazolo[4,3-gh]isoquinolin-6(2H)-
ones (9-aza-anthrapyrazoles). J. Med. Chem. 1998, 41, 5429−5444.
(16) Chou, K. M.; Krapcho, A. P.; Hacker, M. P. Impact of the basic
amine on the biological activity and intracellular distribution of an aza-
anthrapyrazole: BBR 3422. Biochem. Pharmacol. 2001, 62, 1337−1343.
(17) Sissi, C.; Leo, E.; Moro, S.; Capranico, G.; Mancia, A.; Menta,
E.; Krapcho, A. P.; Palumbo, M. Antitumor AZA-anthrapyrazoles:
biophysical and biochemical studies on 8- and 9-aza regioisomers.
Biochem. Pharmacol. 2004, 67, 631−642.
(18) Showalter, H. D. H.; Johnson, J. L.; Werbel, L. M.; Leopold, W.
R.; Jackson, R. C.; Elslager, E. F. 5-[(Aminoalkyl)amino]-substituted
anthra[1,9-cd]pyrazol-6(2H)-ones as novel anticancer agents. synthesis
and biological evaluation. J. Med. Chem. 1984, 27, 253−255.
(19) Erhardt, P.; Khupse, R.; Sarver, J.; Trendel, J. Prodrugs:
Strategic Deployment, Metabolic Considerations and Chemical Design
Principles. In Burger’s Medicinal Chemistry, Drug Discovery and
Development; Abraham, D., Ed.; John Wiley & Sons, Inc.: Hoboken,
NJ, 2010; pp 103−150.
(20) Lee, H. H.; Denny, W. A. A large-scale synthesis of the
bioreductive drug 1,4-bis{[2-(dimethylamino)ethyl]amino}-5,8-dihy-
droxyanthracene-9,10-dione bis-N-oxide (AQ4N). J. Chem. Soc., Perkin
Trans. 1 1999, 2755−2758.
(21) Nishida, C. R.; Montellano, P. R. O. Reductive heme-dependent
activation of the N-oxide prodrug AQ4N by nitric oxide sythase. J.
Med. Chem. 2008, 51, 5118−5120.
(22) Elslager, E. F.; Weinstein, E. A.; Worth, D. F. Synthesis and
biological properties of aminoalkylhydrazines. A unique nitrigen-
nitrogen scission of 1-(2-diethylaminoethyl)-2-(1-phenyl-2-propyl)-
hydrazine. J. Med. Chem. 1964, 7, 493−500.
(23) Krapcho, A. P.; Gallagher, C. E.; Hammach, A.; Hacker, M. P.;
Menta, E.; Oliva, A.; Di Domenico, R.; Da Re, G.; Lotto, A.; Spinelli, S.
Synthesis of hydroxy-substituted aza-analogs of antitumor anthrapyr-
azoles. J. Heterocycl. Chem. 1998, 35, 895−906.
(24) Davis, F. A.; Lamendola, J.; Nadir, U.; Kluger, E. W.; Sedergran,
T. C.; Panunto, T. W.; Billmers, R.; Jenkins, R.; Turchi, I. J.; Watson,
W. H.; Chen, J. S.; Kimura, M. Chemistry of oxaziridine. 1. Synthesis
8227
dx.doi.org/10.1021/jm200984x|J. Med. Chem. 2011, 54, 8224−8227